Literature DB >> 2585929

Studies on serum tocopherol, selenium levels and blood glutathione peroxidase activities in calves with white muscle disease.

Y Hoshino, S Ichijo, S Osame, E Takahashi.   

Abstract

For the purpose of clarifying the cause of white muscle disease (WMD) in calves, tocopherol and selenium levels and blood glutathione peroxidase (GSH-Px) activity were measured on 10 calves with WMD and nine of their dams. The main clinical symptoms of the 10 calves with WMD were motor disturbances including recumbency and stiffness. Serum enzyme activities (GOT, GPT, CPK, LDH) in calves with WMD increased markedly, and this increase was also observed in some of their dams. Serum tocopherol levels of calves with WMD were low, 70% of which showing deficient levels of less than 70 micrograms/100 ml. Serum selenium levels of all the calves were lower than 35 ppb, indicating a deficiency, and were accompanied by low blood GSH-Px activity. alpha-Tocopherol and selenium concentrations in organs were very low. Dams of calves with WMD showed low serum tocopherol levels, 22% of which indicating deficient levels below 150 micrograms/100 ml. Serum selenium levels in dams showed a marked decrease to under 20 ppb, and also low blood GSH-Px activity. Feedstuffs supplied in the farms to affected calves indicated very low alpha-tocopherol contents (below 3 mg/100g DM) and low selenium concentrations below 50 ppb in DM. It was concluded that WMD in calves was attributable to nutritional muscular dystrophy caused by deficiencies in tocopherol and selenium in feedstuffs supplied to their dams.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2585929     DOI: 10.1292/jvms1939.51.741

Source DB:  PubMed          Journal:  Nihon Juigaku Zasshi        ISSN: 0021-5295


  1 in total

1.  White muscle disease in foals: focus on selenium soil content. A case series.

Authors:  Catherine Delesalle; Marco de Bruijn; Sanne Wilmink; Hilde Vandendriessche; Gerben Mol; Berit Boshuizen; Lukas Plancke; Guy Grinwis
Journal:  BMC Vet Res       Date:  2017-05-03       Impact factor: 2.741

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.